Objective. To evaluate the extent to which the world's largest and most well established Conditional Cash Transfer (CCT) program, the Bolsa Família Program (BFP), reduced health inequities in the incidence of AIDS, tuberculosis (TB), and child mortality in Brazil. Design. Health impact evaluation within a large-scale cohort study. Setting. Brazil, from January 1 2004 to December 31 2015. Participants. We use three cohorts totaling 92,382,204 million individuals: i) Cohort 1: 22,788,997 individuals aged 13 and older from 2007 to 2015 for the analysis of AIDS incidence; ii) Cohort 2: 54,759,252 individuals from 2004 to 2015 for the analysis of TB incidence; iii) Cohort 3: 14,833,955 children under the age of 5 from 2004 to 2015 for the analysis of child mortality. Interventions. We began by assessing the excess incidence and mortality attributable to poverty severity. To estimate the reduction in health inequities associated with the BFP, we applied multiple inequality indices. We then conducted impact evaluations of BFP’s effects across wealth deciles, employing Inverse Probability Treatment Weighting (IPTW) multivariable Poisson regressions adjusted for all relevant socioeconomic, demographic, and health variables at the individual, household, and municipal levels. Main outcome measures. Incidence of AIDS, incidence of TB, and child mortality Results. Receiving BFP benefits eliminated the excess incidence and mortality associated with extreme poverty, significantly reducing the Gini, Theil, and Concentration Index values. Among the extremely poor, BFP was associated with reductions in the incidence of AIDS by 49%(RR: 0.51;95%CI:0.48-0.54), TB by 51%(RR:0.49;95%CI:0.48-0.50), and child mortality by 70%(RR:0.30;95%CI:0.28 0.32). These effects diminished progressively as beneficiaries’ poverty levels decreased. Over the past two decades, BFP is estimated to have prevented 99,083 cases of AIDS, 235,489 of TB, and 200,627 child deaths. Conclusions. Conditional Cash Transfer programs can significantly alleviate the burden of AIDS, tuberculosis, and child mortality, with the most pronounced impacts observed among the poorest populations. Their effectiveness follows a gradient aligned with levels of individual vulnerability and can substantially reduce health inequities in low- and middle-income countries.